Kala Bio signs exclusive U.S. deal to distribute Virotek eye genetic tests

Go back to Kala Bio signs exclusive U.S. deal to distribute Virotek eye genetic tests
(NASDAQ: KALA) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.37    52 Week Low $ 
Day High $0.40    P/E N/A 
Day Low $0.34    EPS $ 
Volume 654,424